These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638 [TBL] [Abstract][Full Text] [Related]
11. Complement and cytokine based therapeutic strategies in myasthenia gravis. Tüzün E; Huda R; Christadoss P J Autoimmun; 2011 Sep; 37(2):136-43. PubMed ID: 21636248 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in Japanese patients with ocular myasthenia gravis. Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484 [TBL] [Abstract][Full Text] [Related]
13. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
15. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China. Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131 [TBL] [Abstract][Full Text] [Related]
16. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Huda S; Woodhall MR; Vincent A; Heckmann JM Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303 [TBL] [Abstract][Full Text] [Related]
17. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Vincent A; Leite MI Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434 [TBL] [Abstract][Full Text] [Related]
18. Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. Rose N; Holdermann S; Callegari I; Kim H; Fruh I; Kappos L; Kuhle J; Müller M; Sanderson NSR; Derfuss T Acta Neuropathol; 2022 Nov; 144(5):1005-1025. PubMed ID: 36074148 [TBL] [Abstract][Full Text] [Related]
20. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis. Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]